Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast Cancers

Abstract Background: Machine learning enables complex risk prediction models, but comparative performance with statistical approaches remains context-dependent. We compared statistical and machine learning models for predicting advanced breast cancer risk. Methods: Using data from 968,178 women (40–74 years) undergoing 2,796,459 annual or 812,126 biennial screening mammograms (2005-2019) in the Breast Cancer Surveillance Consortium, we cross-validated models predicting advanced breast cancer within 12 months (annual) or 24 months (biennial) following screening. Models included conventional logistic regression, regularized regressions (LASSO, Elastic net), and machine learning methods (random forests, gradient boosting), considering a modest number of clinical and demographic predictors. Performance was assessed using calibration and area under the receiver operating characteristic curve (AUC). Results: Discrimination was similar across models (AUC 0.677–0.690). Calibration differences were more pronounced. Regularized regressions achieved the most favorable calibration overall and across racial and ethnic groups, with AUC 0.689 (95%CI = 0.676–0.701). Gradient boosting showed comparable AUC but suboptimal calibration (calibration slope 1.12; 95%CI = 1.04–1.20). Conventional logistic regression had slightly lower AUC (0.683; 95%CI = 0.671–0.696) and calibration slope of 0.90 (95%CI = 0.83–0.96). Regression-based approaches were generally well calibrated across racial and ethnic groups (E/O ratio 0.96–1.03; calibration intercept −0.03 to 0.04), with some subgroup deviations in calibration slopes (<1). Conclusions: For predicting advanced breast cancers, regularized regression demonstrated similar discrimination and generally more favorable calibration than other approaches. Impact: In settings with rare outcomes and low dimensional features, regularized regression may offer a practical balance between performance and interpretability.

Authors

Institutions

Publication Details

Journal
Cancer Epidemiology Biomarkers & Prevention
Published
2026-05-14
DOI
https://doi.org/10.1158/1055-9965.epi-25-2052
Primary Topic
AI in cancer detection
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast Cancers

Rebecca A. Hubbard, Jeffrey A. Tice, Charlotte C. Gard, Yu-Ru Su et al.
Cancer Epidemiology Biomarkers & Prevention
AI in cancer detection
article

Performance of Statistical and Machine Learning Risk Prediction Models for Advanced Breast Cancers

Rebecca A. Hubbard, Jeffrey A. Tice, Charlotte C. Gard, Yu-Ru Su, Brian L. Sprague, Shuai Chen, Karla Kerlikowske, Diana L. Miglioretti, Thomas P. Ahern
article en

Abstract

Abstract Background: Machine learning enables complex risk prediction models, but comparative performance with statistical approaches remains context-dependent. We compared statistical and machine learning models for predicting advanced breast cancer risk. Methods: Using data from 968,178 women (40–74 years) undergoing 2,796,459 annual or 812,126 biennial screening mammograms (2005-2019) in the Breast Cancer Surveillance Consortium, we cross-validated models predicting advanced breast cancer within 12 months (annual) or 24 months (biennial) following screening. Models included conventional logistic regression, regularized regressions (LASSO, Elastic net), and machine learning methods (random forests, gradient boosting), considering a modest number of clinical and demographic predictors. Performance was assessed using calibration and area under the receiver operating characteristic curve (AUC). Results: Discrimination was similar across models (AUC 0.677–0.690). Calibration differences were more pronounced. Regularized regressions achieved the most favorable calibration overall and across racial and ethnic groups, with AUC 0.689 (95%CI = 0.676–0.701). Gradient boosting showed comparable AUC but suboptimal calibration (calibration slope 1.12; 95%CI = 1.04–1.20). Conventional logistic regression had slightly lower AUC (0.683; 95%CI = 0.671–0.696) and calibration slope of 0.90 (95%CI = 0.83–0.96). Regression-based approaches were generally well calibrated across racial and ethnic groups (E/O ratio 0.96–1.03; calibration intercept −0.03 to 0.04), with some subgroup deviations in calibration slopes (<1). Conclusions: For predicting advanced breast cancers, regularized regression demonstrated similar discrimination and generally more favorable calibration than other approaches. Impact: In settings with rare outcomes and low dimensional features, regularized regression may offer a practical balance between performance and interpretability.

Cancer Epidemiology Biomarkers & Prevention
New Mexico State University (US), University of Vermont (US), John Brown University (US), University of California, San Francisco (US), Kaiser Permanente Washington Health Research Institute (US), University of San Francisco (US), University of California, Davis (US)
Gender equality
Openalex Percentile: Top 3%
AI in cancer detection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.